Evidence map›Paper›PMID 25081628›Full record

ReviewCold Spring Harbor perspectives in medicine2014

Cell-autonomous effector mechanisms against mycobacterium tuberculosis.

John D MacMicking

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Phenotypic adaptation ofFrontiers in cellular and infection microbiology · 2022
    Review
  9. Article
  10. IFN-γInfection and immunity · 2021
    Article
  11. Review
  12. Article
  13. Review
  14. Systematic Identification ofMolecular & cellular proteomics : MCP · 2017
    Article
  15. Microbiology spectrum · 2017
    Review
  16. Article
  17. Molecular basis of mycobacterial survival in macrophages.Cellular and molecular life sciences : CMLS · 2017
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

John D MacMickingDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut 06510.
Yale University · US

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Immune control of tuberculosis by IFN-gamma-inducible LRG-47R01AI068041 · NIAID · YALE UNIVERSITY · PI MACMICKING, JOHN DAVID · 2006 to 2021
$5.9M
NCATS NIH HHS UL1 TR000142NIAID NIH HHS R01 AI068041NIAID NIH HHS R01 AI068041-07
6 · The paper itself

Abstract

Few pathogens run the gauntlet of sterilizing immunity like Mycobacterium tuberculosis (Mtb). This organism infects mononuclear phagocytes and is also ingested by neutrophils, both of which possess an arsenal of cell-intrinsic effector mechanisms capable of eliminating it. Here Mtb encounters acid, oxidants, nitrosylating agents, and redox congeners, often exuberantly delivered under low oxygen tension. Further pressure is applied by withholding divalent Fe²⁺, Mn²⁺, Cu²⁺, and Zn²⁺, as well as by metabolic privation in the form of carbon needed for anaplerosis and aromatic amino acids for growth. Finally, host E3 ligases ubiquinate, cationic peptides disrupt, and lysosomal enzymes digest Mtb as part of the autophagic response to this particular pathogen. It is a testament to the evolutionary fitness of Mtb that sterilization is rarely complete, although sufficient to ensure most people infected with this airborne bacterium remain disease-free.

Indexed as

Immunity, InnateAmino AcidsAntimicrobial Cationic PeptidesCarbonCationsHumansHydrogen-Ion ConcentrationIronLysosomesMacrophagesMycobacterium tuberculosisOxidative StressPhagocytesReactive Oxygen SpeciesReceptors, CalcitriolReceptors, InterferonAmino AcidsAntimicrobial Cationic PeptidesCarbonCationsIronReactive Oxygen SpeciesReceptors, CalcitriolReceptors, InterferonReceptors, Interleukin-1Receptors, Tumor Necrosis FactorToll-Like Receptors

Identifiers

PMID25081628
PMCPMC4184915
OpenAlexW2156876531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.